Ken Fisher's position in Astrazeneca plc is currently worth $770 Million. That's 0.37% of their equity portfolio (72nd largest holding). The first Astrazeneca plc trade was made in Q3 2015. Since then Ken Fisher bought shares 30 more times and sold shares on four occasions. The stake costed the investor $392 Million, netting the investor a gain of 96% so far.